1. Home
  2. DAIO vs EVAX Comparison

DAIO vs EVAX Comparison

Compare DAIO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

HOLD

Current Price

$2.86

Market Cap

29.1M

Sector

Industrials

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$3.38

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
EVAX
Founded
1969
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.1M
27.4M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
DAIO
EVAX
Price
$2.86
$3.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.22
$12.33
AVG Volume (30 Days)
21.1K
52.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,769,000.00
N/A
Revenue This Year
$7.40
$128.77
Revenue Next Year
$2.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$1.20
52 Week High
$3.49
$12.15

Technical Indicators

Market Signals
Indicator
DAIO
EVAX
Relative Strength Index (RSI) 40.07 44.96
Support Level $2.56 $2.56
Resistance Level $2.90 $3.66
Average True Range (ATR) 0.15 0.26
MACD -0.02 0.09
Stochastic Oscillator 18.04 72.12

Price Performance

Historical Comparison
DAIO
EVAX

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: